The potential of antiviral agents to control classical swine fever: A modelling study

Antiviral Research

Volumn 99, Issue 3, 2013, Pages 245-250

  Backer, Jantien A ^a   Vrancken, Robert ^b   Neyts, Johan ^b,c   Goris, Nesya ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Okapi Sciences NV   (Belgium)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral; Classical swine fever; Control strategy; Pestivirus; Stochastic simulation model

Indexed keywords

ANTIVIRUS AGENT; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIVIRAL THERAPY; ARTICLE; CLASSICAL SWINE FEVER; CONTROL STRATEGY; CONTROLLED STUDY; EPIDEMIC; NONHUMAN; PRIORITY JOURNAL; SWINE; VACCINATION; VIRUS TRANSMISSION; COMPARATIVE EFFECTIVENESS; HERD; INFECTION CONTROL; PIGLET; SOW (SWINE); ANIMAL; BIOLOGICAL MODEL; CLASSICAL SWINE FEVER VIRUS; DRUG EFFECTS; IMMUNOLOGY; NETHERLANDS; PHYSIOLOGY; VIROLOGY; DRUG EFFECT; PESTIVIRUS; STOCHASTIC SIMULATION MODEL;

ANIMALS; ANTIVIRAL AGENTS; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; MODELS, BIOLOGICAL; NETHERLANDS; SWINE; VACCINATION; VIRAL VACCINES;

ANTIVIRAL; CLASSICAL SWINE FEVER; CONTROL STRATEGY; PESTIVIRUS; STOCHASTIC SIMULATION MODEL;

EID: 84884570995     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.06.013     Document Type: Article

References (15)

1. Backer J.A., Hagenaars T.J., Van Roermund H.J.W., De Jong M.C.M. Modelling the effectiveness and risks of vaccination strategies to control classical swine fever epidemics. J. R. Soc. Interface 2009, 6:849-861. 10.1098/rsif.2008.0408.
2. Boender G.J., Nodelijk G.A., Hagenaars T.J., Elbers A.R.W., De Jong M.C.M. Local spread of classical swine fever upon virus introduction into The Netherlands: mapping of areas at high risk. BMC Vet. Res. 2008, 4:9. 10.1186/1746-6148-4-9.
3. Contingency plan classical swine fever, 2007. Beleidsdraaiboek Klassieke Varkenspest, version 2.1, pp. 147 (in Dutch).
4. Council Directive 2001/89/EC, 2001. Commission of the European Communities. Official Journal of the European Union, L316, pp. 5-35.
5. Dewulf J., Laevens H., Koenen F., Mintiens K., de Kruif A. Efficacy of E2-sub-unit marker and C-strain vaccines in reducing horizontal transmission of classical swine fever virus in weaner pigs. Prev. Vet. Med. 2004, 65:121-133. 10.1016/j.prevetmed.2004.05.010.
6. Elbers A.R.W., Stegeman A., Moser H., Ekker H.M., Smak J.A., Pluimers F.H. The classical swine fever epidemic 1997-1998 in the Netherlands: descriptive epidemiology. Prev. Vet. Med. 1999, 42:157-184.
7. Floegel-Niesmann G. Classical swine fever (CSF) marker vaccine Trial III. Evaluation of discriminatory ELISAs. Vet. Microbiol. 2001, 83:121-136.
8. Goris N., Vandenbussche F., De Clercq K. Potential of antiviral therapy and prophylaxis for controlling rna viral infections of livestock. Antiviral Res. 2008, 78:170-178. 10.1016/j.antiviral.2007.10.003.
9. Klinkenberg D., Everts-van der Wind A., Graat E.A.M., De Jong M.C.M. Quantification of the effect of control strategies on classical swine fever epidemics. Math. Biosci. 2003, 186:145-173. 10.1016/j.mbs.2003.08.005.
10. Land- en tuinbouwcijfers, 2011. LEI & Centraal Bureau voor de Statistiek (CBS), ISSN 1386-9566, pp. 262 (in Dutch).
11. Ribbens S., Goris N., Neyts J., Dewulf J. Classical swine fever outbreak containment using antiviral supplementation: a potential alternative to emergency vaccination and stamping-out. Prev. Vet. Med. 2012, 106:34-41. 10.1016/j.prevetmed.2012.03.002.
12. Stegeman A., Elbers A.R.W., Bouma A., de Smit H., de Jong M.C.M. Transmission of classical swine fever virus within herds during the 1997-1998 epidemic in The Netherlands. Prev. Vet. Med. 1999, 42:201-218. 10.1016/S0167-5877(99)00076-8.
13. Van Rijn P.A., Bossers A., Wensvoort G., Moormann R.J.M. Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. J. Gen. Virol. 1996, 77:2737-2745.
14. Vrancken R., Haegeman A., Dewulf J., Paeshuyse J., Puerstinger G., Tignon M., Le Potier M.F., Neyts J., Koenen F. The reduction of CSFV transmission to untreated pigs by the pestivirus inhibitor BPIP: a proof of concept. Vet. Microbiol. 2009, 139:365-368. 10.1016/j.vetmic.2009.06.026.
15. Vrancken R., Haegeman A., Paeshuyse J., Puerstinger G., Rozenski J., Wright M., Tignon M., Le Potier M.F., Neyts J., Koenen F. Proof of concept for the reduction of classical swine fever infection in pigs by a novel viral polymerase inhibitor. J. Gen. Virol. 2009, 90:1335-1342. 10.1099/vir.0.008839-0.